These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2224590)

  • 1. 1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss.
    Epstein S; Schlosberg M; Fallon M; Thomas S; Movsowitz C; Ismail F
    Calcif Tissue Int; 1990 Sep; 47(3):152-7. PubMed ID: 2224590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat.
    Movsowitz C; Epstein S; Fallon M; Ismail F; Thomas S
    J Lab Clin Med; 1990 Jan; 115(1):62-8. PubMed ID: 2299257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone.
    Movsowitz C; Schlosberg M; Epstein S; Ismail F; Fallon M; Thomas S
    J Orthop Res; 1990 Sep; 8(5):635-41. PubMed ID: 2388102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
    Gunness-Hey M; Hock JM; Gera I; Fonseca J; Poser J; Bevan J; Raisz LG
    Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-Dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone Gla protein and bone histomorphometry.
    Jowell PS; Epstein S; Fallon MD; Reinhardt TA; Ismail F
    Endocrinology; 1987 Feb; 120(2):531-6. PubMed ID: 3492365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration.
    Movsowitz C; Epstein S; Fallon M; Ismail F; Thomas S
    Endocrinology; 1988 Nov; 123(5):2571-7. PubMed ID: 3262506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gautvik KM; Gordeladze JO
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption.
    Movsowitz C; Epstein S; Ismail F; Fallon M; Thomas S
    J Bone Miner Res; 1989 Jun; 4(3):393-8. PubMed ID: 2788358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo.
    Cvetkovic M; Mann GN; Romero DF; Liang XG; Ma Y; Jee WS; Epstein S
    Transplantation; 1994 Apr; 57(8):1231-7. PubMed ID: 7513912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat.
    Schlosberg M; Movsowitz C; Epstein S; Ismail F; Fallon MD; Thomas S
    Endocrinology; 1989 May; 124(5):2179-84. PubMed ID: 2785025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined flurbiprofen and cyclosporin-A does not attenuate bone loss and exaggerates renal impairment.
    Sass DA; Rucinski B; Bryer HP; Mann GN; Yuan Z; Ma Y; Jee WS; Epstein S
    Bone; 1996 Oct; 19(4):381-6. PubMed ID: 8894144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmon calcitonin prevents cyclosporin-A-induced high turnover bone loss.
    Stein B; Takizawa M; Katz I; Joffe I; Berlin J; Fallon M; Epstein S
    Endocrinology; 1991 Jul; 129(1):92-8. PubMed ID: 2055207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
    Katz I; Li M; Joffe I; Stein B; Jacobs T; Liang XG; Ke HZ; Jee W; Epstein S
    J Bone Miner Res; 1994 Jan; 9(1):59-67. PubMed ID: 8154310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that cyclosporine G is less deleterious to rat bone in vivo than cyclosporine A.
    Stein B; Takizawa M; Schlosberg M; Movsowitz C; Fallon M; Berlin JA; Epstein S
    Transplantation; 1992 Mar; 53(3):628-32. PubMed ID: 1549857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.
    Mann GN; Jacobs TW; Buchinsky FJ; Armstrong EC; Li M; Ke HZ; Ma YF; Jee WS; Epstein S
    Endocrinology; 1994 Sep; 135(3):1077-83. PubMed ID: 8070349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17 beta-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A.
    Joffe I; Katz I; Jacobs T; Stein B; Takizawa M; Liu C; Berlin J; Epstein S
    Endocrinology; 1992 Mar; 130(3):1578-86. PubMed ID: 1537307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of cyclosporine H to elucidate the possible mechanisms of cyclosporine A-induced osteopenia in the rat.
    Rucinski B; Liu CC; Epstein S
    Metabolism; 1994 Sep; 43(9):1114-8. PubMed ID: 8084286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alendronate prevents cyclosporin A-induced osteopenia in the rat.
    Sass DA; Bowman AR; Yuan Z; Ma Y; Jee WS; Epstein S
    Bone; 1997 Jul; 21(1):65-70. PubMed ID: 9213009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.